diabetes mellitus, type 2
Showing NaN - NaN of 59
Diabetes, Type 2 Trial in Worldwide (BI 10773, Placebo, Sitagliptin 100mg)
Completed
- Diabetes Mellitus, Type 2
- BI 10773
- +2 more
-
Birmingham, Alabama
- +242 more
Jul 14, 2014
Diabetes, Type 2 Trial in Worldwide (linagliptin low dose, , linagliptin medium dose)
Completed
- Diabetes Mellitus, Type 2
- linagliptin low dose
- +2 more
-
De Pinte, Belgium
- +83 more
Jun 17, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo, BI 10773)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- BI 10773
-
Muscle Shoals, Alabama
- +67 more
May 16, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 10773 high dose, Placebo identical to BI 10773 low dose, BI 10773)
Completed
- Diabetes Mellitus, Type 2
- Placebo identical to BI 10773 high dose
- +2 more
-
Birmingham, Alabama
- +147 more
May 16, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo, Canagliflozin, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +4 more
-
Anniston, Alabama
- +82 more
Jun 26, 2013
Diabetes, Type 2 Trial in Worldwide (Placebo, 25 mg PF-04991532, 75 mg PF-04991532)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +5 more
-
Little Rock, Arkansas
- +41 more
Mar 11, 2013
Diabetes, Type 1, Diabetes, Type 2, Asthma Trial in Worldwide (Technosphere Insulin)
Terminated
- Diabetes Mellitus, Type 1
- +2 more
- Technosphere Insulin
-
Phoenix, Arizona
- +77 more
May 3, 2012
Diabetes, Type 2 Trial in Worldwide (Tesaglitazar, Pioglitazone)
Terminated
- Diabetes Mellitus, Type 2
-
Birmingham, Alabama
- +170 more
Nov 18, 2010